Log In
Company Data

Amarin Corporation plc

Rating: Log in to view
Healthcare
Biotechnology
Rating: Log in to view
Advanced Market Data
Ticker
AMRN
Current Price
$1.28 1.59%
Market Cap
$521.8M
Price Target
Refer to Report
Volume
1.3M
52wk Range
$1.04 - $2.23
Advanced Market Data

Overview

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa.

Research Reports

    Other Considerations

    Medivation Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    Medivation Inc.
    MDVN (NGS)
    $81.44
    3.8B
    1.9M
    $26.41 - $81.48
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Synthorx Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    Synthorx Inc.
    THOR (NGS)
    $67.99
    2.2B
    110.1K
    $11.05 - $71.9
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    GenVec Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    GenVec Inc.
    GNVC (NSC)
    $7.193
    12.3B
    5.2M
    $2.7 - $10.44
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    MAIA Biotechnology Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    MAIA Biotechnology Inc.
    MAIA Biotechnology Inc.
    MAIA (AMX)
    $2.354
    $2.4(-1.92%)
    32.1M
    46.6K
    $2.12 - $9.64
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data
    Baudax Bio Inc.
    Company
    Ticker
    Price
    Previous
    Mkt Cap
    Volume
    52wk Range
    ‌
    Baudax Bio Inc.
    Baudax Bio Inc.
    BXRX (Nasdaq)
    $0.5846
    $0.56(4.41%)
    3.5M
    1.9M
    $0.5 - $37.72
    Fundamental Analysis:
    Log in to view
    Rating: Log in to view
    Advanced Market Data

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In
    © 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
    Log In